232 related articles for article (PubMed ID: 34401153)
21. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.
Bilici A; Seker M; Ustaalioglu BB; Canpolat N; Salepci T; Gumus M
J Korean Med Sci; 2011 Apr; 26(4):574-6. PubMed ID: 21468267
[TBL] [Abstract][Full Text] [Related]
22. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Chanan-Khan A; Cramer P; Demirkan F; Fraser G; Silva RS; Grosicki S; Pristupa A; Janssens A; Mayer J; Bartlett NL; Dilhuydy MS; Pylypenko H; Loscertales J; Avigdor A; Rule S; Villa D; Samoilova O; Panagiotidis P; Goy A; Mato A; Pavlovsky MA; Karlsson C; Mahler M; Salman M; Sun S; Phelps C; Balasubramanian S; Howes A; Hallek M;
Lancet Oncol; 2016 Feb; 17(2):200-211. PubMed ID: 26655421
[TBL] [Abstract][Full Text] [Related]
23. Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.
Waldthaler C; Stauder R; Schnallinger M; Schreieck S; Hager J; Oexle H; Zangerl G; Verdorfer I; Zabernigg A; Gastl G; Fiegl M
Wien Klin Wochenschr; 2011 May; 123(9-10):269-75. PubMed ID: 21479652
[TBL] [Abstract][Full Text] [Related]
24. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
[TBL] [Abstract][Full Text] [Related]
25. Primary pulmonary MALT-lymphoma mimicking pulmonary infection: a case report and overview on the pertinent literature.
Giulia P; Carla G; Cristian R; Riccardo V; Maria CM; Cristiano C; Massimiliano P; Filippo L
Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(3):260-263. PubMed ID: 32476855
[TBL] [Abstract][Full Text] [Related]
26. MALT lymphoma: forget surgery?
Fischbach W
Dig Dis; 2013; 31(1):38-42. PubMed ID: 23797121
[TBL] [Abstract][Full Text] [Related]
27. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ; Niederle N; Maschmeyer G; Banat GA; von Grünhagen U; Losem C; Kofahl-Krause D; Heil G; Welslau M; Balser C; Kaiser U; Weidmann E; Dürk H; Ballo H; Stauch M; Roller F; Barth J; Hoelzer D; Hinke A; Brugger W;
Lancet; 2013 Apr; 381(9873):1203-10. PubMed ID: 23433739
[TBL] [Abstract][Full Text] [Related]
28. Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Freret ME; Tringale KR; Boe L; Imber BS; Joffe E; Yahalom J; Hajj C
Leuk Lymphoma; 2023 Dec; 64(13):2195-2201. PubMed ID: 37706509
[TBL] [Abstract][Full Text] [Related]
29. BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA.
Bogeljić Patekar M; Milunović V; Mišura Jakobac K; Perica D; Mandac Rogulj I; Kursar M; Planinc-Peraica A; Ostojić Kolonić S
Acta Clin Croat; 2018 Sep; 57(3):542-553. PubMed ID: 31168188
[TBL] [Abstract][Full Text] [Related]
30. Successful Endoscopic Resection of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Unresponsive to Helicobacter pylori Eradication Therapy.
Choi J
Clin Endosc; 2022 Jan; 55(1):136-140. PubMed ID: 33190433
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
Nakamura S; Hojo M
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614921
[TBL] [Abstract][Full Text] [Related]
32. Primary pulmonary marginal zone lymphoma: an unusual cause of pulmonary infiltrates.
Smyth R; Sloan JM; Burks E; Hawkins F
Respirol Case Rep; 2021 Aug; 9(8):e00806. PubMed ID: 34221408
[TBL] [Abstract][Full Text] [Related]
33. A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.
Wei Z; Li J; Cheng Z; Yuan L; Liu P
J Thorac Dis; 2017 Apr; 9(4):1081-1092. PubMed ID: 28523163
[TBL] [Abstract][Full Text] [Related]
34. A case of Helicobactor pylori negative low-grade gastric MALT lymphoma in an elderly female, successfully treated with rituximab.
Mainali NR; Aryal MR; Khal RS; Alweis R
Am J Case Rep; 2013; 14():467-70. PubMed ID: 24250832
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.
Ogura M; Ando K; Taniwaki M; Watanabe T; Uchida T; Ohmachi K; Matsumoto Y; Tobinai K;
Cancer Sci; 2011 Sep; 102(9):1687-92. PubMed ID: 21624007
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus (HIV)-negative, API2-MALT1 fusion-negative bronchus-associated lymphoid tissue (BALT) lymphoma in a young male.
Okamoto M; Inaba T; Uchida R; Fuchida S; Ochiai N; Okano A; Ashihara E; Inagaki H; Nakamura S; Shimazaki C
Leuk Lymphoma; 2004 Oct; 45(10):2165-8. PubMed ID: 15370267
[TBL] [Abstract][Full Text] [Related]
38. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database.
Dote S; Inose R; Goto R; Kobayashi Y; Muraki Y
Hematol Oncol; 2023 Aug; 41(3):354-362. PubMed ID: 36792059
[TBL] [Abstract][Full Text] [Related]
39. Bendamustine's emerging role in the management of lymphoid malignancies.
Rummel MJ; Gregory SA
Semin Hematol; 2011 Apr; 48 Suppl 1():S24-36. PubMed ID: 21530769
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin's Lymphoma or Mantle-Cell Lymphoma.
Edina BC; Rinaldi I
Acta Med Indones; 2022 Apr; 54(2):316-323. PubMed ID: 35818660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
